News
2022-02-14 08:59
iZafe Group AB (publ.) - announces that since the new Dosell was approved by all partners, 450 Swedish medication robots have been produced and shipped. Our factory, like so many others, was affected by the coronavirus, which led to a near-halt in production...
2022-01-14 14:05
iZafe Group hereby announces that the partner Careium AB has signed an agreement with a municipality in Skåne, which has chosen to introduce the Swedish made medication robot Dosell in its operations. Contacts Carl-Fredrik Bothén, Chief Marketing...
2022-01-12 14:05
A video summary from Anders Segerström CEO iZafe Group AB of the year 2021 and an insight into 2022. Here is a summary of the past year 2021 and an insight into 2022 from Anders Segerström, CEO of iZafe. Click on the link HERE to watch the movie...
2021-12-20 11:12
iZafe Group AB has held a partner interview between Anders Segerström, CEO of iZafe Group AB and Geir Tore Jakobsen, CEO of Hepro AS. In the interview between the companies, we clarify certain issues posed to us and at the same time we provide an...
2021-12-16 16:10
iZafe Group hereby announces that Careium AB, formerly Doro Care, is ordering forty Dosell medication robots. Careium formerly Doro Care is the market leader with new innovation in Sweden and Norway and one of the leading players in the UK and the Netherlands...
2021-12-14 11:40
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - hereby announces that the Municipality of Söderköping is extending the agreement by 12 months and our partner Zafe Care Systems AB. Söderköping continues its...
2021-12-06 14:15
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - releases "Nobody wants to take the wrong medicine" (only available in Swedish) a report on pharmaceutical use and safety in medication. The report was made in connection...
2021-12-03 14:39
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - hereby announces that the first pharmaceutical robots adapted for the Italian consumer market have now been sent to Sempli Farma in Italy for the pilot project. In October this...
2021-12-02 13:15
Stockholm, Sweden - iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - hereby announces that Zafe Care Systems is ordering 50 Dosell and is now initiating offensive marketing activities to bring the pharmaceutical robot to market. Zafe Care Systems...
2021-11-29 13:40
iZafe Group AB (”iZafe”) has entered into an agreement with Mangold Fondkommission AB (Mangold) as liquidity provider for the iZafe share on Nasdaq First North Growth Market. The purpose of the liquidity provider is to improve the liquidity...
2021-11-29 08:30
Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) - today November 29, releases its Q3 Interim Report. Summary of financial performance • Net sales for the quarter totaled SEK 38 thousand (701). Sales for the quarter...
2021-11-24 11:20
Hepro AS has last issued a final approval of the new version of Dosell and has officially approved the pharmaceutical robot in its entirety for the Norwegian market. As Dosell is a medical technology product that requires high security and functionality...
2021-11-24 09:25
Stockholm, Sweden, iZafe Group AB (publ) ("iZafe" or "the Company") announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its third quarter report. The report...
2021-11-11 12:45
Stockholm, Sweden, iZafe Group AB (publ) ("iZafe" or "the Company") today announced the appointment of Carl-Fredrik Bothén as Chief Marketing Officer. In his new role, Bothén will be an integral part of the executive...
2021-10-21 11:15
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED KINGDOM, THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH...
2021-10-14 20:05
iZafe Group AB (publ.) (”iZafe” or ”the Company”) announces that the price for the consumer version of Dosell will be SEK 299 per month. Dosell Consumer is a subscription service without binding period or notice period. A subscription...
2021-10-14 09:20
iZafe Group AB (publ.) (“iZafe” or “the Company”) announces the initiation of the launch of Dosell Consumer as an end product to the healthcare service Sempli Farma. Today, 25 pharmacies in Italy have already subscribed to the...
2021-10-13 09:00
iZafe Group AB (publ) (”iZafe” or ”the Company”) announces that they have filed for several completions of their PCT patent application. Thus, the Company enables a greater geographic patent protection, which is part of iZafe’s...
2021-10-12 08:30
iZafe Group AB (publ) (”iZafe” or ”the Company”) announces that Vice Chairman of the Board Göran Hermansson and CEO Anders Segerström are subscribing for an additional of combined 458,000 units in the ongoing rights issue...
2021-10-04 13:55
iZafe Group AB (publ.) announces that Dosell Consumer will be launched on October 18 via Apoteket AB. The first delivery of Dosell Consumer will be sent to Apoteket today, October 4, before the start of sales. In connection with the launch, the media...
2021-09-29 12:50
iZafe Group AB (publ.) announces that for the second year in a row, the Company is one of the nominated entries to win the Golden Pill. iZafe Group participates in the competition with Dosell Consumer - Sweden's first pharmaceutical robot for consumers...